Literature DB >> 25064292

Non-medical use of prescription stimulants for weight loss, disordered eating, and body image.

Amy J Jeffers1, Eric G Benotsch2.   

Abstract

OBJECTIVE: There has been minimal research on the non-medical use of prescription stimulants (NMUPS), such as Adderall and Ritalin, normally used to treat Attention Deficit Hyperactivity Disorder (ADHD) for the purpose of weight loss. The current study examined the prevalence and correlates of this use in a young adult sample.
METHOD: College students (N=707) completed an online survey assessing NMUPS, in general and for weight loss, disordered eating behaviors and attitudes, body image, and recreational drug use.
RESULTS: Overall, 4.4% of participants reported NMUPS for the purpose of weight loss with 56.7% reporting receiving the medication from friends. Individuals reporting NMUPS for weight loss had higher body image concerns and had higher eating disorder symptomatology. Vomiting for weight loss as well as laxative, diet pill, or diuretic use were robustly associated with NMUPS for weight loss. DISCUSSION: Results suggest that NMUPS for weight loss is relatively common and that this behavior is related to other harmful behaviors. Eating disorder prevention and intervention work should include this behavior when assessing unhealthy weight control behaviors.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adderall; Appetite suppression; Eating disorder; Prescription misuse; Prescription stimulants; Weight loss

Mesh:

Substances:

Year:  2014        PMID: 25064292     DOI: 10.1016/j.eatbeh.2014.04.019

Source DB:  PubMed          Journal:  Eat Behav        ISSN: 1471-0153


  8 in total

1.  Motivations for the nonmedical use of prescription drugs in a longitudinal national sample of young adults.

Authors:  Tess K Drazdowski; Lourah M Kelly; Wendy L Kliewer
Journal:  J Subst Abuse Treat       Date:  2020-04-29

Review 2.  Acupuncture Therapies for Individuals with Overweight or Obesity: An Overview of Systematic Reviews.

Authors:  Jiaxin Chen; Johannah L Shergis; Xinfeng Guo; Anthony Lin Zhang; Hanlin Wang; Chuanjian Lu; Charlie C Xue; Changcai Xie
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-30       Impact factor: 3.249

3.  College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants: Implications for intervention designs.

Authors:  Melissa M Ross; Amelia M Arria; Jessica P Brown; C Daniel Mullins; Jason Schiffman; Linda Simoni-Wastila; Susan dosReis
Journal:  Addict Behav       Date:  2017-12-06       Impact factor: 3.913

Review 4.  Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.

Authors:  Johanna Daubner; Muhammad Imran Arshaad; Christina Henseler; Jürgen Hescheler; Dan Ehninger; Karl Broich; Oliver Rawashdeh; Anna Papazoglou; Marco Weiergräber
Journal:  Neural Plast       Date:  2021-01-13       Impact factor: 3.599

5.  Attention-deficit/hyperactivity disorder-specific stimulant misuse, mood, anxiety, and stress in college-age women at high risk for or with eating disorders.

Authors:  Elise L Gibbs; Andrea E Kass; Dawn M Eichen; Ellen E Fitzsimmons-Craft; Mickey Trockel; Denise E Wilfley
Journal:  J Am Coll Health       Date:  2016-01-29

6.  Prevalence and demographic, substance use, and mental health correlates of fasting among U.S. college students.

Authors:  Kyle T Ganson; Rachel F Rodgers; Stuart B Murray; Jason M Nagata
Journal:  J Eat Disord       Date:  2021-07-21

7.  Brain doping: stimulants use and misuse among a sample of Italian college students.

Authors:  S Majori; D Gazzani; S Pilati; J Paiano; A Sannino; S Ferrari; E Checchin
Journal:  J Prev Med Hyg       Date:  2017-06

Review 8.  Prescription Drug Misuse: Taking a Lifespan Perspective.

Authors:  Ty S Schepis; Dalton L Klare; Jason A Ford; Sean Esteban McCabe
Journal:  Subst Abuse       Date:  2020-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.